Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives...

Together with Brenda Schulman, Director at the Max Planck Institute of Biochemistry in Martinsried, PROXIDRUGS speaker Ivan Đikić will...

The list of Highly Cited Researchers identifies pioneers in their respective fields who repeatedly demonstrated significant and broad...

In the latest issue of Cell Chemical Biology, PROXIDRUGS scientists Varun Shah and Ivan Đikić comment on an article published by Simpson...

On October 17th and 18th, the second annual PROXIDRUGS meeting took place in Bad Brückenau. Exciting research results were presented, and...

The PROXIDRUGS consortium actively took part in the EMBO Workshop “Cancer cell signaling: Linking molecular knowledge on cancer therapy”...

In a press release issued by Fraunhofer Society, the PROXIDRUGS consortium is introduced to the broad public. PROXIDRUGS project leader...

A oncology project from Goethe University was now chosen for funding within the beLAB2122 BRIDGE partnership. On the academic side, the...

The German Chemical Biology Lectureship is awarded by the Joint Working Group Chemical Biology to outstanding young scientists to honor...

PROXIDRUGS speaker Ivan Đikić has been awarded with an Advanced Grant of the European Research Council (ERC). This is the third time he...